Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma - method-comparison evaluations.

Almeida SM, Marquie-Beck J, Bhatt A, Letendre S, McCutchan A, Ellis R; HNRC Group.

Arq Neuropsiquiatr. 2014 Jul;72(7):500-5.

2.

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder.

McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, Ances BM, Grant I; CHARTER Group.

Neurology. 2012 Feb 14;78(7):485-92. doi: 10.1212/WNL.0b013e3182478d64.

3.

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Moore DJ, Arce M, Moseley S, McCutchan JA, Marquie-Beck J, Franklin DR, Vaida F, Achim CL, McArthur J, Morgello S, Simpson DM, Gelman BB, Collier AC, Marra CM, Clifford DB, Heaton RK, Grant I; Charter Group and HNRC Group.

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):316-23. doi: 10.1176/appi.neuropsych.23.3.316.

4.

Incidence of post-dural puncture headache in research volunteers.

de Almeida SM, Shumaker SD, LeBlanc SK, Delaney P, Marquie-Beck J, Ueland S, Alexander T, Ellis RJ.

Headache. 2011 Nov-Dec;51(10):1503-10. doi: 10.1111/j.1526-4610.2011.01959.x. Epub 2011 Jul 28.

5.

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.

Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2011 Feb;17(1):63-9. doi: 10.1007/s13365-010-0013-2. Epub 2011 Jan 19.

6.

Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.

de Almeida SM, Bhatt A, Riggs PK, Durelle J, Lazzaretto D, Marquie-Beck J, McCutchan A, Letendre S, Ellis R.

J Neurovirol. 2010 Feb;16(1):6-12. doi: 10.3109/13550280903514776.

7.

Role of metabolic syndrome components in HIV-associated sensory neuropathy.

Ances BM, Vaida F, Rosario D, Marquie-Beck J, Ellis RJ, Simpson DM, Clifford DB, McArthur JC, Grant I, McCutchan JA; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Metabolic Study Group.

AIDS. 2009 Nov 13;23(17):2317-22. doi: 10.1097/QAD.0b013e328332204e.

8.

Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.

Ances BM, Bhatt A, Vaida F, Rosario D, Alexander T, Marquie-Beck J, Ellis RJ, Letendre S, Grant I, McCutchan JA; HIV Neurobehavioral Research Center (HNRC) Group.

J Neurovirol. 2009 May;15(3):249-56. doi: 10.1080/13550280902962443.

9.

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.

Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, McCutchan JA, Morgello S, Grant I; CHARTER Group.

Ann Neurol. 2008 Nov;64(5):566-72. doi: 10.1002/ana.21484.

10.

Impact of long-term treatment with neurotoxic dideoxynucleoside antiretrovirals: implications for clinical care in resource-limited settings.

Hung CF, Gibson SA, Letendre SL, Lonergan JT, Marquie-Beck JA, Vaida F, Ellis RJ.

HIV Med. 2008 Oct;9(9):731-7. doi: 10.1111/j.1468-1293.2008.00615.x. Epub 2008 Jul 21.

11.

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ; CHARTER Group.

Arch Neurol. 2008 Jan;65(1):65-70. doi: 10.1001/archneurol.2007.31.

12.

Low CSF leptin levels are associated with worse learning and memory performance in HIV-infected men.

Huang JS, Letendre S, Marquie-Beck J, Cherner M, McCutchan JA, Grant I, Ellis R.

J Neuroimmune Pharmacol. 2007 Dec;2(4):352-8. Epub 2007 Oct 10.

PMID:
18040853
13.

The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system.

Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I; CHARTER Group.

J Neuroimmune Pharmacol. 2007 Mar;2(1):120-7. Epub 2007 Jan 3.

PMID:
18040835
14.

Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease.

Woods SP, Morgan EE, Marquie-Beck J, Carey CL, Grant I, Letendre SL; HIV Neurobehavioral Research Center (HNRC) Group.

Cogn Behav Neurol. 2006 Dec;19(4):217-21.

15.

Valproic acid does not affect markers of human immunodeficiency virus disease progression.

Ances BM, Letendre S, Buzzell M, Marquie-Beck J, Lazaretto D, Marcotte TD, Grant I, Ellis RJ; HNRC Group.

J Neurovirol. 2006 Oct;12(5):403-6.

PMID:
17065134
16.

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.

Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ.

J Neurovirol. 2006 Apr;12(2):100-7.

PMID:
16798671
17.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.

Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I; HNRC Group.

AIDS. 2005 Oct;19 Suppl 3:S72-8.

PMID:
16251831
18.

Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV.

Capparelli EV, Holland D, Okamoto C, Gragg B, Durelle J, Marquie-Beck J, van den Brande G, Ellis R, Letendre S; HNRC Group.

AIDS. 2005 Jun 10;19(9):949-52.

PMID:
15905676
19.

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine.

Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I; HIV Neurobehavioral Research Center Group.

Neurology. 2005 Apr 26;64(8):1343-7.

PMID:
15851720
20.

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, G√ľnthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.

J Virol. 2005 Feb;79(3):1772-88.

21.

The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid.

Letendre S, Marquie-Beck J, Singh KK, de Almeida S, Zimmerman J, Spector SA, Grant I, Ellis R; HNRC Group.

J Neuroimmunol. 2004 Dec;157(1-2):193-6.

PMID:
15579297
22.

CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults.

Singh KK, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, Spector SA.

J Neuroimmunol. 2004 Dec;157(1-2):185-92.

PMID:
15579296

Supplemental Content

Loading ...
Support Center